- AU$135.09m
- AU$96.64m
- AU$5.91m
Australia Stock Exchange release from DIMERIX : Secondary Trading Notice Pursuant to Section 708A(5)(e)
Australia Stock Exchange release from DIMERIX : Notification regarding unquoted securities - DXB
Australia Stock Exchange release from DIMERIX : Notification regarding unquoted securities - DXB
Australia Stock Exchange release from DIMERIX : Notification regarding unquoted securities - DXB
Australia Stock Exchange release from DIMERIX : Application for quotation of securities - DXB
Brief: Dimerix Says 20 Mln Ordinary Shares To Be Issued At A$0.20 Each Under SPP
Australia Stock Exchange release from DIMERIX : Dimerix Closes SPP Oversubscribed
Australia Stock Exchange release from DIMERIX : PRE_NR Ends: 09:28:28
Australia Stock Exchange release from DIMERIX : Results of Meeting
Australia Stock Exchange release from DIMERIX : AGM Presentation
Australia Stock Exchange release from DIMERIX : CEO's Address to Shareholders
Australia Stock Exchange release from DIMERIX : Virtual Meeting Voting and Registration Guide
Brief: Dimerix Says DMX-200 Recommended For Regulatory Approval In COVID-19 Study In India
Australia's Dimerix climbs on India nod to test drug in COVID-19 patients
Australia Stock Exchange release from DIMERIX : DMX-200 CLARITY COVID-19 Study Approval in India
Australia Stock Exchange release from DIMERIX : PRE_NR Ends: 10:06:17
Australia Stock Exchange release from DIMERIX : Change of Director's Interest Notices - JW, HA and SP
Australia Stock Exchange release from DIMERIX : Change in substantial holding
Brief: Dimerix Announces Phase 3 Study In FSGS Kidney Patients Commences